Studies have demonstrated that CTX treatment can promote the nuclear localization of EGFR, whereas elevated levels of nuclear EGFR were found in CTX-resistance non-small-cell lung cancer cells [25]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.